Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gremlin 1 Expression Distinguishes Stem Cells Able to Regenerate Bones and Cartilage in Adult Mice

By LabMedica International staff writers
Posted on 26 Jan 2015
A newly identified type of stem cell in the bone marrow of adult mice was found to be capable of regenerating both bone and cartilage.

Investigators at Columbia University (New York, NY, USA) reported in the January 15, 2015, online edition of the journal Cell that expression of the bone morphogenetic protein (BMP) antagonist gremlin 1 defined a population of osteochondroreticular (OCR) stem cells in the bone marrow. More...


BMPs are considered to constitute a group of pivotal morphogenetic signals, orchestrating tissue architecture throughout the body. Deletion of gremlin 1 in mice caused increased bone formation and increased trabecular bone volume, whereas overexpression caused inhibition of bone formation and osteopenia.

The investigators found that OCR stem cells self-renewed and generated osteoblasts, chondrocytes, and reticular marrow stromal cells, but not adipocytes. OCR stem cells were concentrated within the metaphysis of long bones not in the perisinusoidal space and were needed for bone development, bone remodeling, and fracture repair. Gremlin 1 expression also identified intestinal reticular stem cells (iRSCs) that are cells of origin for the periepithelial intestinal mesenchymal sheath. Thus, gremlin 1 expression identified distinct connective tissue stem cells in both the bone (OCR stem cells) and the intestine (iRSCs).

"Our findings raise the possibility that drugs or other therapies can be developed to stimulate the production of OCR stem cells and improve the body's ability to repair bone injury—a process that declines significantly in old age," said senior author Dr. Timothy C. Wang, professor of medicine at Columbia University.

Related Links:

Columbia University



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Portable Electronic Pipette
Mini 96
Alcohol Testing Device
Dräger Alcotest 7000
New
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The enhanced collaboration builds upon the successful launch of the AmplideX Nanopore Carrier Plus Kit in March 2025 (Photo courtesy of Bio-Techne)

Bio-Techne and Oxford Nanopore to Accelerate Development of Genetics Portfolio

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded its agreement with Oxford Nanopore Technologies (Oxford, UK) to broaden Bio-Techne's ability to develop a portfolio of genetic products on Oxford... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.